当前位置:
X-MOL 学术
›
Nat. Rev. Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Taking the path of most resistance
Nature Reviews Cancer ( IF 72.5 ) Pub Date : 2021-08-17 , DOI: 10.1038/s41568-021-00398-2 Anna Dart 1
Nature Reviews Cancer ( IF 72.5 ) Pub Date : 2021-08-17 , DOI: 10.1038/s41568-021-00398-2 Anna Dart 1
Affiliation
Haas et al. show that acquired resistance to a targeted therapy can result in cross-resistance to immunotherapy through the induction of an immune-evasive microenvironment.
中文翻译:
走阻力最大的路
哈斯等人。表明对靶向治疗的获得性耐药可通过诱导免疫逃避微环境导致对免疫治疗的交叉耐药。
更新日期:2021-08-17
中文翻译:
走阻力最大的路
哈斯等人。表明对靶向治疗的获得性耐药可通过诱导免疫逃避微环境导致对免疫治疗的交叉耐药。